首页 / 院系成果 / 成果详情页

Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals  期刊论文  

  • 编号:
    1464cd23-f6d8-4e38-9150-ad4738ce5f79
  • 作者:
  • 语种:
    英文
  • 期刊:
    INTERNATIONAL JOURNAL OF CANCER ISSN:0020-7136 2017 年 140 卷 5 期 (1068 - 1081) ; MAR 1
  • 收录:
  • 关键词:
  • 摘要:

    Statins have been implicated in the regulation of cell proliferation, apoptosis and tumor progression in cancer patients and statin use at the time of cancer diagnosis has been reported to be associated with reduced cancer risk and improved survival, irrespective of concomitant anti-cancer therapy. A systematic literature search of relevant databases through May 2015 was conducted to identify studies assessing the prognostic impact of statin use on prognostic outcomes in cancer patients. Literature search identified 95 cohort studies that met the inclusion criteria. A meta-analysis of 55 articles showed that statin use was significantly associated with decreased risk of all-cause mortality (HR 0.70, 95% Cl 0.66 to 0.74) compared with nonusers. The observed pooled estimates were retained for cancer-specific mortality (HR 0.60, 95% Cl 0.47 to 0.77), progressionfree survival (HR 0.67, 95% Cl 0.56 to 0.81), recurrence-free survial (HR 0.74, 95% Cl 0.65 to 0.83) and disease-free survival (HR 0.53, 95% Cl 0.40 to 0.72). These associations almost remained consistent across those outcomes when stratified by publication type, tumour location, study design, sample size, initiation of statins, disease stage, research country, follow-up duration or research hospital involved. Subgroup analyses according to initiation of statins showed postdiagnosis statin users (HR 0.65, 95% Cl 0.54 to 0.79) gained significantly more recurrence-free survival benefit than prediagnosis statin users (HR 0.86, 95% Cl 0.77 to 0.96) (p for interaction = 0.018). Statin therapy has potential survival benefit for patients with malignancy. Further large-scale prospective studies emphasising survival outcomes of individual cancer type are strongly encouraged.

  • 推荐引用方式
    GB/T 7714:
    Mei Zubing,Liang Mining,Li Lezhi, et al. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals [J].INTERNATIONAL JOURNAL OF CANCER,2017,140(5):1068-1081.
  • APA:
    Mei Zubing,Liang Mining,Li Lezhi,Zhang Yi,&Yang Wei.(2017).Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals .INTERNATIONAL JOURNAL OF CANCER,140(5):1068-1081.
  • MLA:
    Mei Zubing, et al. "Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals" .INTERNATIONAL JOURNAL OF CANCER 140,5(2017):1068-1081.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:47 下载次数:0
浏览次数:47
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部